These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9543371

  • 21. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
    Wilmer WA, Hebert LA, Lewis EJ, Rohde RD, Whittier F, Cattran D, Levey AS, Lewis JB, Spitalewitz S, Blumenthal S, Bain RP.
    Am J Kidney Dis; 1999 Aug; 34(2):308-14. PubMed ID: 10430979
    [Abstract] [Full Text] [Related]

  • 22. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G.
    Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
    [Abstract] [Full Text] [Related]

  • 23. [Reduction of proteinuria by enalapril, in children with nephrotic syndrome resistant to prednisone].
    Pérez-Cortés G, Santos-Atherton D, López-Montaño E.
    Gac Med Mex; 1988 Mar; 124(9-10):371-4. PubMed ID: 2854521
    [No Abstract] [Full Text] [Related]

  • 24. The effect of enalapril on nephrotic proteinuria and determination of serum angiotensin-converting enzyme before and after treatment.
    Bianchini G, Letizia C, Domenici A, Scavo D.
    Drugs Exp Clin Res; 1991 Mar; 17(5):263-9. PubMed ID: 1661665
    [Abstract] [Full Text] [Related]

  • 25. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, Abassi Z.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
    [Abstract] [Full Text] [Related]

  • 26. Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome.
    Liern M, Colazo A, Vallejo G, Zotta E.
    Nefrologia (Engl Ed); 2021 Oct; 41(3):304-310. PubMed ID: 36166246
    [Abstract] [Full Text] [Related]

  • 27. Losartan and enalapril are comparable in reducing proteinuria in children.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C.
    Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
    [Abstract] [Full Text] [Related]

  • 28. Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantation.
    Osugi Y, Yamada H, Hosoi G, Noma H, Ikemiya M, Ishii T, Sako M.
    Int J Hematol; 2006 Jun; 83(5):454-8. PubMed ID: 16787879
    [Abstract] [Full Text] [Related]

  • 29. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.
    Praga M, Hernández E, Montoyo C, Andrés A, Ruilope LM, Rodicio JL.
    Am J Kidney Dis; 1992 Sep; 20(3):240-8. PubMed ID: 1519604
    [Abstract] [Full Text] [Related]

  • 30. [Long-term effect of angiotensin-converting inhibitors in children with proteinuria].
    Camacho Díaz JA, Giménez Llort A, García García L, Jiménez González R.
    An Esp Pediatr; 2001 Sep; 55(3):219-24. PubMed ID: 11676896
    [Abstract] [Full Text] [Related]

  • 31. Management of congenital nephrotic syndrome.
    Kovacevic L, Reid CJ, Rigden SP.
    Pediatr Nephrol; 2003 May; 18(5):426-30. PubMed ID: 12687455
    [Abstract] [Full Text] [Related]

  • 32. Successful treatment of a patient with nephrotic syndrome associated with chronic lymphocytic leukemia.
    Takahashi F, Ogawa Y, Hasebe N, Natori S, Tokusashi Y, Miyokawa N, Kikuchi K.
    Intern Med; 2000 Mar; 39(3):256-9. PubMed ID: 10772132
    [Abstract] [Full Text] [Related]

  • 33. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA, Esezobor CI, Lesi FE.
    Pan Afr Med J; 2016 Mar; 25():258. PubMed ID: 28293374
    [Abstract] [Full Text] [Related]

  • 34. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [Abstract] [Full Text] [Related]

  • 35. [Congenital nephrotic syndrome].
    Hattori M.
    Nihon Rinsho; 2004 Oct; 62(10):1861-6. PubMed ID: 15500131
    [Abstract] [Full Text] [Related]

  • 36. Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome.
    Milliner DS, Morgenstern BZ.
    Pediatr Nephrol; 1991 Sep; 5(5):587-90. PubMed ID: 1911144
    [Abstract] [Full Text] [Related]

  • 37. Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome.
    Van Dyck M, Proesmans W.
    Pediatr Nephrol; 2004 Jun; 19(6):688-90. PubMed ID: 15064939
    [Abstract] [Full Text] [Related]

  • 38. Beneficial effect of triple treatment plus immunoglobulin in experimental nephrotic syndrome.
    Akman S, Kalay S, Akkaya B, Koyun M, Akbaş H, Baysal YE, Guven AG.
    Pediatr Nephrol; 2009 Jun; 24(6):1173-80. PubMed ID: 19224250
    [Abstract] [Full Text] [Related]

  • 39. Severe nephrotic syndrome in a patient with Schönlein-Henoch purpura: complete remission after cyclosporin A.
    Schmaldienst S, Winkler S, Breiteneder S, Hörl WH.
    Nephrol Dial Transplant; 1997 Apr; 12(4):790-2. PubMed ID: 9141015
    [No Abstract] [Full Text] [Related]

  • 40. [Nephrotic syndrome: therapeutic possibilities].
    Meesen BP.
    Ned Tijdschr Geneeskd; 1992 May 16; 136(20):992. PubMed ID: 1317511
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.